No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13391359 |
chr2:212771670-212771671 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs187883451 |
chr2:212771690-212771691 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs192513217 |
chr2:212771691-212771692 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs568547168 |
chr2:212771701-212771702 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs184850372 |
chr2:212771725-212771726 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs557277195 |
chr2:212771727-212771728 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs542751885 |
chr2:212771746-212771747 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs141617576 |
chr2:212771781-212771782 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs76146470 |
chr2:212771790-212771791 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs369264885 |
chr2:212771796-212771797 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs114792967 |
chr2:212771839-212771840 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs188128824 |
chr2:212771857-212771858 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs558972369 |
chr2:212771874-212771875 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs73073363 |
chr2:212771956-212771957 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs562074964 |
chr2:212771959-212771960 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs561126239 |
chr2:212771989-212771990 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs530006881 |
chr2:212772139-212772140 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs73073366 |
chr2:212772171-212772172 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs73073370 |
chr2:212772221-212772222 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs201226873 |
chr2:212772226-212772227 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs530917830 |
chr2:212772259-212772260 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs192081970 |
chr2:212772282-212772283 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs562139970 |
chr2:212772358-212772359 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs73073372 |
chr2:212772374-212772375 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs377569041 |
chr2:212772431-212772432 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs150100134 |
chr2:212772512-212772513 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs73077349 |
chr2:212772517-212772518 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs536972399 |
chr2:212772522-212772523 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs554304657 |
chr2:212772566-212772567 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs374832475 |
chr2:212772567-212772568 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs546865606 |
chr2:212772587-212772588 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs10187387 |
chr2:212772588-212772589 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs200675935 |
chr2:212772589-212772590 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs138639820 |
chr2:212772590-212772591 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs559136658 |
chr2:212772615-212772616 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs540222858 |
chr2:212772637-212772638 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs375195329 |
chr2:212772643-212772644 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs529711389 |
chr2:212772686-212772687 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs575819558 |
chr2:212772728-212772729 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs79323300 |
chr2:212772760-212772761 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs112792994 |
chr2:212772769-212772770 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs56232132 |
chr2:212772780-212772781 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs149313335 |
chr2:212772860-212772861 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs540555081 |
chr2:212772895-212772896 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs146274579 |
chr2:212772951-212772952 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs139277158 |
chr2:212773003-212773004 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs184626443 |
chr2:212773038-212773039 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs562201284 |
chr2:212773056-212773057 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs189323199 |
chr2:212773069-212773070 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs116446379 |
chr2:212773096-212773097 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|